Amarin Corp Plc (AMRN)

[sts66]

We argue that as part of the sales promotion/physician education process, this advantageous lipid profile would not escape physicians’ attention

But apparently Lovaza causing up to a 49% rise in LDL-C *has* escaped the good doctor's attentions for > 15 yrs......hard to believe they'd simply ignore it given LDL-C's sole accepted lipid marker for elevated CV risk.....